XML 47 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity Method Investments (Tables)
 12 Months Ended
Mar. 31, 2018
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Equity Method Investments
Summarized financial information for TOKIN follows (amounts in thousands):
 
March 31,
2017
Current assets continuing operations
$
204,654

Assets held for sale (current) (1)
118,983

Noncurrent assets continuing operations
285,952

Current liabilities continuing operations
375,433

Liabilities held for sale (current) (1)
50,008

Noncurrent liabilities continuing operations
65,657

___________________________________________
(1) As discussed in Note 2, “Acquisitions,” TOKIN sold its EMD business on April 14, 2017.

 
19 Day Period Ended April 19, 2017
Fiscal Year March 31, 2017
Fiscal Year March 31, 2016
Net sales
$
23,649

$
328,822

$
301,898

Gross profit
6,647

74,465

67,409

Net income (loss)
247,786

128,502

(42,995
)



A reconciliation between TOKIN’s net loss and KEMET’s equity investment income (loss) follows (amounts in thousands):
 
19 Day Period Ended April 19, 2017
 
Fiscal Year March 31, 2017
 
Fiscal Year March 31, 2016
TOKIN net income (loss)
$
247,786

 
$
128,502

 
$
(42,995
)
KEMET’s equity ownership %
34
%
 
34
%
 
34
%
Equity income (loss) from TOKIN before Adjustments
$
84,247

 
$
43,691

 
$
(14,618
)
 
 
 
 
 
 
Adjustments:
 
 
 
 
 
Amortization and depreciation
(113
)
 
(2,210
)
 
(1,625
)
Removal of EMD memo accounts
(8,981
)
 
—

 
—

Inventory profit elimination
24

 
162

 
(163
)
Equity income (loss) from TOKIN
75,177

 
41,643

 
(16,406
)
 
 
 
 
 
 
Acquired equity method investment income (loss)
1,015

 
—

 
—

Equity income (loss) from equity method investments
$
76,192

 
$
41,643

 
$
(16,406
)

A reconciliation between TOKIN’s net assets and KEMET’s equity investment balance follows (amounts in thousands):
 
March 31, 2017
Investment in TOKIN
$
63,416

Purchase price accounting basis adjustment:

Property, plant and equipment (1)
3,080

Technology (1)
(8,691
)
Long-term debt (1)
(1,067
)
Goodwill
(7,590
)
Indemnity asset for legal investigation
(8,500
)
Inventory profit elimination (2)
208

Other
(569
)
KEMET’s 34% interest of TOKIN’s equity
$
40,287

___________________________________________
(1) Depreciated or amortized over the estimated lives.
(2) Adjusted each period for any activity
The following table provides a reconciliation of equity method investments to the Company's consolidated balance sheet (amounts in thousands):
 
 
March 31,
 
 
2018
 
2017
Nippon Yttrium Co., Ltd ("NYC")
 
$
8,148

 
$
—

NT Sales Co., Ltd ("NTS")
 
998

 
—

Investment in Novasentis
 
2,870

 
—

Investment in TOKIN
 
—

 
63,416

 
 
$
12,016

 
$
63,416
Schedule of Related Party Transactions
Summarized transactions between KEC and TOKIN are as follows (amounts in thousands):
 
19 Day Period Ended April 19, 2017
 
Fiscal Year March 31, 2017
 
Fiscal Year March 31, 2016
KEC’s sales to TOKIN
$
727

 
$
17,100

 
$
21,061

TOKIN’s sales to KEMET
356

 
8,341

 
5,912

 
March 31,
2017
Accounts receivable
$
2,662

Accounts payable
1,378

Management service agreement receivable (1)
775

___________________________________________
(1) In accordance with the Stockholders’ Agreement, KEC entered into a management services agreement with TOKIN to provide services for which KEC was being reimbursed.
Summarized transactions between TOKIN and NTS are as follows (amounts in thousands):
 
 
Fiscal Year March 31, 2018
KEMET's sales to NTS
 
$
52,883

NTS' sales to KEMET
 
1,616